Adventris Pharmaceuticals

Adventris makes cancer vaccines

adventris.com

Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.

About

Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com Adventris Pharmaceuticals is a Y Combinator company (Winter 2023). YC-listed status: Active.

Location
Baltimore, MD, USA
Added via
web
Ownership
unclaimed

Where to go

Products

  • Adventris Pharmaceuticals — Off-the-shelf cancer vaccines targeting KRAS and other poorly immunogenic oncogenes to prevent and treat common cancers. · Other

Links